Dividend Information About Healthpeak: Everything You Need to Know Before Its Ex-Dividend Date on Sep 19, 2025

Healthpeak Properties (DOC) has announced a cash dividend of $0.1017 per share, with the ex-dividend date set for Sep 19, 2025. This payment will be distributed on Sep 30, 2025, to shareholders of record. The dividend was officially declared on Jul 7, 2025, marking a notable reduction compared to the average of the last 10 dividends, which stood at $0.4448 per share. The most recent dividend was also paid at $0.1017 per share on Aug 29, 2025, following the same cash dividend structure. Investors should note that this current payout is significantly lower than the historical average, suggesting a potential shift in the company’s dividend policy or financial strategy. With the ex-dividend date fast approaching, investors must ensure ownership of shares before Sep 19, 2025, to qualify for this dividend distribution.

Over the past week, Healthpeak has attracted significant investor attention due to recent developments in its stock rating and ownership changes. Notably, Raymond James recently upgraded the stock to “Outperform” from “Market Perform,” setting a new price target of $20.00 per share. Analysts indicated that this move was driven by a combination of recent stock underperformance, an attractive valuation, and a well-supported dividend. The firm highlighted Healthpeak’s strong fundamentals and its position within the healthcare real estate sector as key factors in the upgrade. Since the last update, the stock has shown modest movement, with a slight increase of 0.41% as of late, reflecting renewed investor confidence.

Another significant development is the recent reduction in institutional holdings. Pensionfund DSM Netherlands cut its stake in Healthpeak by 8.9% during the first quarter, signaling a strategic shift in portfolio allocation. This reduction has raised questions among market observers about broader investor sentiment and the company’s long-term appeal to large institutional players. Meanwhile, Foresight Group Ltd Liability Partnership also decreased its position by 7.3%, further reinforcing concerns over near-term market dynamics. These changes, while not directly tied to Healthpeak’s core fundamentals, suggest a more cautious approach from major shareholders.

In addition, new options for Healthpeak’s stock have begun trading for the January 2028 expiration, offering investors more flexibility in hedging and speculation strategies. This development, coupled with the recent analyst upgrades, points to increased market activity and interest in the stock. As of late, the broader healthcare REIT sector has seen mixed performance, with some firms gaining traction while others face headwinds. Healthpeak’s recent upgrade and the positive outlook from Raymond James have positioned it as a more favorable option for those looking to capitalize on the sector’s potential.

In conclusion, Healthpeak Properties (DOC) has recently announced a cash dividend of $0.1017 per share, with the ex-dividend date set for Sep 19, 2025. Investors must purchase shares before this date to be eligible for the dividend payment on Sep 30, 2025. The company has also seen a recent upgrade from Raymond James to “Outperform,” alongside notable reductions in institutional holdings and increased options activity. These factors collectively reflect a complex landscape for Healthpeak, with both positive and cautionary signals for investors to consider.